I have 22 consecutive profitable trades of 15% or better. How is this possible? Every day there are hundreds of stocks setting new highs, no matter what happens in the overall market. Many of these stocks are still at very reasonable valuations. Afraid of buying stocks at their highs? Think of it this way: a new high is really a future floor for companies with solid financial underpinnings. Quantitative momentum modeling makes it easy to identify stocks that can continue this upward momentum trend. Why does this happen? It's really very simple..ask me about what investors and cows have in common. I am $$$ MR. MARKET $$$. I AM HUGE!!! Bring me your finest meats and cheeses. You can join in on the fun. Register for free and you'll be able to post messages on this forum and also receive emails when $$$ MR. MARKET $$$ makes his own trades. ($$$MR. MARKET$$$ is a proprietary investor and does not provide individual financial advice. The stocks mentioned on this forum do not represent individual buy or sell recommendations and should not be viewed as such. Individual investors should consider speaking with a professional investment adviser before making any investment decisions.)
If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
just upgraded price target again
Goodbodys upgrade from London 3/1/04
I especially like this part :
"Adjusting our model to incorporate the revised Antegren numbers, potential upside on pricing and as an aquisition target, we now conservatively value Elan at between $11,77 and $17,47. We believe that even at the upper level, the stock would not be seen as overpriced.
We therefore believe there is considerable headroom for the stock and retain our Buy recommendation with an increased price target of $17.00. This represents a 18% premium on the current price, which we consider undemanding given the potential upside to current numbers and the sector appetite for blockbuster drugs "
Comment